ENNAR PHARMA
The purpose of the Ennar Pharma is the research and development of products for the treatment of psoriasis as well as the consultation, manufacture, distribution and trade of developed products for the treatment of psoriasis. The company can use processes and patents. The Company may enter into any kind of business and enter into contracts that are conducive to the purpose of the Company or directly or indirectly related thereto. The Company may participate in, or associate with, other companies. The Company may acquire, hold or sell real estate. It may set up branches and agencies in Germany or abroad by resolution of the Board of Directors
ENNAR PHARMA
Industry:
Alternative Medicine Medical Pharmaceutical Real Estate
Founded:
2010-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Status:
Active
More informations about "Ennar Pharma"
ENN-10 - Drug Targets, Indications, Patents - Synapse
Ennar Pharma AG. Drug Highest Phase Discontinued Discovery. First Approval Date-Regulation-Related. 100 Clinical Results associated with ENN-10. Login to view more data. 100 …See details»
Ennar Pharmaceuticals AF - Drug pipelines, Patents, Clinical
Clinical Trials associated with Ennar Pharmaceuticals AF. NCT01566578 / Unknown status Phase 1. A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical …See details»
Ennar Pharma AG | VentureRadar
Entwicklung von Arzneimitteln zur Behandlung von Psoriasis(Schuppenflechte). Affiliation: Universität Basel ... Find out more about Ennar Pharma AG, Biotech, Drug discovery, …See details»
Ennar Pharma AG - VentureRadar
Ennar Pharma AG Follow Following Location: Switzerland. Founded in 2010. Private Company " Entwicklung von Arzneimitteln zur Behandlung von Psoriasis(Schuppenflechte). Affiliation: …See details»
Ennar Pharma | Company | RadialReport
The purpose of the Ennar Pharma is the research and development of products for the treatment of psoriasis as well as the consultation, manufacture, distribution and trade of developed …See details»
Organization | Ennar Pharmaceuticals AF - Purdue University
Ennar Pharmaceuticals AF Report issue. For profit Phase 1. Founded: Basel Switzerland (2010) Status: Defunct (2010) Organization Overview ...See details»
Ennar Pharma - Crunchbase
Development of medicines for the treatment of psoriasis.See details»
Home | Ennar Exports
Ennar Exports is an organization of professionals engaged in export of pharma, surgical &hospital equipment, generic & branded medicines, healthcare solutions and medical-field …See details»
Ennar Pharma AG - Drug pipelines, Patents, Clinical trials - Synapse
Explore Ennar Pharma AG with its drug pipeline, therapeutic area, technology platform, , Drug:ENN-11, ENN-10.See details»
About - Ennar Exports
Ennar Exports is an organization of professionals engaged in export of pharma, surgical &hospital equipment, generic & branded medicines, healthcare solutions and medical-field related …See details»
ENNAR EXPORTS Company Profile | Mumbai, Maharashtra, India ...
Find company research, competitor information, contact details & financial data for ENNAR EXPORTS of Mumbai, Maharashtra. Get the latest business insights from Dun & Bradstreet. …See details»
Human recombinant epidermal growth factor in Plaque Psoriasis
Mar 21, 2012 August 2, 2012 updated by: Ennar Pharmaceuticals AF. Investigation of EGF-Receptor Downregulation by topical EGF (dermal cream) exposition. Study Overview. Status. …See details»
Similar companies to Ennar Pharma AG | VentureRadar
Ennar Pharma AG profile. Similar Companies to Ennar Pharma AG. Export. RSMSR Ltd. Privately Held. Founded 2010. Switzerland. Entwicklung und Vertrieb von Diagnostik-Kits für …See details»
ENN-11 - Drug Targets, Indications, Patents - Synapse - Patsnap
Ennar Pharma AG. Drug Highest Phase Discontinued Discovery. First Approval Date-Regulation-Related. 100 Clinical Results associated with ENN-11. Login to view more data. 100 …See details»
Pharma firm urged to share new 'game-changer' HIV drug
May 30, 2024 More than 300 politicians, health experts and celebrities called Thursday for US pharmaceutical giant Gilead to allow generic versions of a promising new HIV drug to be …See details»
Searchlight: Emnar Pharma poised to turn around after a
May 27, 2024 Emnar Pharma Pvt. Ltd (formerly Emmennar Pharma), a part of the Virchow group, is likely to see a rebound in profitability for the fiscal year ended March 2024, owing to …See details»
ENN-01 - Drug Targets, Indications, Patents - Synapse - Patsnap
Ennar Pharmaceuticals AF. Drug Highest Phase Pending Phase 1. First Approval Date-Regulation-Login to view timeline. Related. 100 Clinical Results associated with ENN-01. …See details»
Emmennar Pharma Pvt - Overview, News & Similar companies
Who is Emmennar Pharma Pvt. Emmennar is committed to provide safe workplaces for all Group companies. Improvement in safety performance owes as much to management attention an d …See details»